ES2125210T3 - Metodo para la sintesis de un compuesto de bencimidazol. - Google Patents

Metodo para la sintesis de un compuesto de bencimidazol.

Info

Publication number
ES2125210T3
ES2125210T3 ES96942702T ES96942702T ES2125210T3 ES 2125210 T3 ES2125210 T3 ES 2125210T3 ES 96942702 T ES96942702 T ES 96942702T ES 96942702 T ES96942702 T ES 96942702T ES 2125210 T3 ES2125210 T3 ES 2125210T3
Authority
ES
Spain
Prior art keywords
bencimidazol
synthesis
compound
carried out
reaction sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96942702T
Other languages
English (en)
Other versions
ES2125210T1 (es
Inventor
Anders Gustavsson
Ake Kallstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of ES2125210T1 publication Critical patent/ES2125210T1/es
Application granted granted Critical
Publication of ES2125210T3 publication Critical patent/ES2125210T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

UN PROCESO PARA LA FABRICACION DE OMEPRAZOL A PARTIR DE ALCOHOL PIRMETILICO VIA CLORURO DE PIRMETILO Y PIRMETAZOL CARACTERIZADO EN QUE LA SECUENCIA DE REACCION COMPLETA SE LLEVA A CABO SIN AISLAR O PURIFICAR INTERMEDIOS. ADEMAS EN QUE LA REACCION SE LLEVA A CABO EN UN SISTEMA SOLVENTE PRINCIPAL COMUN PARA TODA LA SECUENCIA DE REACCION E INERTE A LOS REACTIVOS FORMADOS DURANTE EL PROCESO Y UTILIZADOS EN EL PROCESO. EL PROCESO SEGUN LA INVENCION PUEDE INCLUIR TAMBIEN UN PASO ADICIONAL DE PURIFICACION.
ES96942702T 1995-12-15 1996-12-05 Metodo para la sintesis de un compuesto de bencimidazol. Expired - Lifetime ES2125210T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504503A SE521100C2 (sv) 1995-12-15 1995-12-15 Förfarande för framställning av en bensimidazolförening

Publications (2)

Publication Number Publication Date
ES2125210T1 ES2125210T1 (es) 1999-03-01
ES2125210T3 true ES2125210T3 (es) 2002-02-01

Family

ID=20400614

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96942702T Expired - Lifetime ES2125210T3 (es) 1995-12-15 1996-12-05 Metodo para la sintesis de un compuesto de bencimidazol.

Country Status (40)

Country Link
US (1) US5958955A (es)
EP (1) EP0868423B1 (es)
JP (1) JP3523267B2 (es)
KR (1) KR100433436B1 (es)
CN (1) CN1113879C (es)
AR (1) AR004834A1 (es)
AT (1) ATE205201T1 (es)
AU (1) AU704422B2 (es)
CA (1) CA2238864C (es)
CO (1) CO4750654A1 (es)
CZ (1) CZ288661B6 (es)
DE (2) DE69615052T2 (es)
DK (1) DK0868423T3 (es)
DZ (1) DZ2137A1 (es)
EE (1) EE03768B1 (es)
EG (1) EG23859A (es)
ES (1) ES2125210T3 (es)
HK (1) HK1010539A1 (es)
HR (1) HRP960581B1 (es)
HU (1) HUP9900110A3 (es)
IL (1) IL124856A (es)
IS (1) IS1891B (es)
MA (1) MA24026A1 (es)
MX (1) MX9804603A (es)
MY (1) MY115661A (es)
NO (1) NO314306B1 (es)
NZ (1) NZ324482A (es)
PL (1) PL186132B1 (es)
PT (1) PT868423E (es)
RU (1) RU2166502C2 (es)
SE (1) SE521100C2 (es)
SI (1) SI0868423T1 (es)
SK (1) SK282347B6 (es)
TN (1) TNSN96148A1 (es)
TR (1) TR199801070T2 (es)
TW (1) TW460474B (es)
UA (1) UA62921C2 (es)
WO (1) WO1997022603A1 (es)
YU (1) YU49420B (es)
ZA (1) ZA9610067B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SK283805B6 (sk) 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
US6303787B1 (en) * 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
DE19951960C2 (de) * 1999-10-28 2002-06-27 Gruenenthal Gmbh Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ZA200706613B (en) * 2004-12-16 2009-03-25 Cipla Ltd Process
CN100393712C (zh) * 2006-01-23 2008-06-11 中国科学院成都有机化学有限公司 苯并咪唑型质子泵抑止剂及其前体的改进制备和分离纯化方法
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
EP2125783A2 (en) * 2007-02-21 2009-12-02 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
CN101492459B (zh) * 2008-01-25 2011-04-27 山东轩竹医药科技有限公司 含烷氧乙酰基二氢异噁唑并吡啶化合物
CN101497603B (zh) * 2008-01-30 2012-11-07 山东轩竹医药科技有限公司 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
CN103664885A (zh) * 2013-12-12 2014-03-26 武汉工程大学 苯并咪唑型质子泵抑制剂中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US461997A (en) * 1891-10-27 Sand-pump or other pipes
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
US4619997A (en) * 1984-09-06 1986-10-28 The Upjohn Company Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening

Also Published As

Publication number Publication date
EG23859A (en) 2007-11-18
TR199801070T2 (xx) 1998-08-21
CA2238864A1 (en) 1997-06-26
MX9804603A (es) 1998-10-31
NO314306B1 (no) 2003-03-03
ZA9610067B (en) 1997-06-17
JP3523267B2 (ja) 2004-04-26
CZ288661B6 (cs) 2001-08-15
EP0868423A1 (en) 1998-10-07
IS4750A (is) 1998-05-22
EE03768B1 (et) 2002-06-17
ATE205201T1 (de) 2001-09-15
JP2000502101A (ja) 2000-02-22
IS1891B (is) 2003-09-19
DE868423T1 (de) 1999-06-02
CN1204332A (zh) 1999-01-06
DE69615052T2 (de) 2002-06-27
CZ168598A3 (cs) 1998-09-16
SE9504503L (sv) 1997-06-16
AR004834A1 (es) 1999-03-10
US5958955A (en) 1999-09-28
CN1113879C (zh) 2003-07-09
IL124856A0 (en) 1999-01-26
DZ2137A1 (fr) 2002-10-23
TNSN96148A1 (fr) 2005-03-15
HRP960581B1 (en) 2001-12-31
TW460474B (en) 2001-10-21
PL327334A1 (en) 1998-12-07
KR100433436B1 (ko) 2004-07-16
MY115661A (en) 2003-08-30
SI0868423T1 (en) 2002-04-30
KR20000064399A (ko) 2000-11-06
NZ324482A (en) 2000-04-28
ES2125210T1 (es) 1999-03-01
PL186132B1 (pl) 2003-10-31
DE69615052D1 (de) 2001-10-11
SK76898A3 (en) 1998-12-02
UA62921C2 (en) 2004-01-15
HRP960581A2 (en) 1998-02-28
EP0868423B1 (en) 2001-09-05
HUP9900110A3 (en) 2002-10-28
DK0868423T3 (da) 2001-12-03
YU49420B (sh) 2006-01-16
CA2238864C (en) 2006-01-24
NO982624L (no) 1998-06-08
EE9800183A (et) 1998-12-15
MA24026A1 (fr) 1997-07-01
CO4750654A1 (es) 1999-03-31
IL124856A (en) 2002-12-01
PT868423E (pt) 2002-02-28
AU704422B2 (en) 1999-04-22
AU1155097A (en) 1997-07-14
YU64296A (sh) 1999-07-28
WO1997022603A1 (en) 1997-06-26
RU2166502C2 (ru) 2001-05-10
SE521100C2 (sv) 2003-09-30
SK282347B6 (sk) 2002-01-07
SE9504503D0 (sv) 1995-12-15
NO982624D0 (no) 1998-06-08
HK1010539A1 (en) 1999-06-25
HUP9900110A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
ES2125210T3 (es) Metodo para la sintesis de un compuesto de bencimidazol.
DE59805688D1 (de) Vorrichtung und verfahren zur parallel-chromatographie
FI960403A0 (fi) Merkkireagenssi ja analyysimenetelmä
KR970705644A (ko) 신규 염기쌍 설계를 이용한 비특이적 혼성화의 감소방법(reduction of nonspecific hybridization by using novel base-pairing schemes)
DK0668272T3 (da) Fremgangsmåde til fremstilling af tetrazolylforbindelser
PT81036B (pt) Processo para a preparacao de derivados do acido cis, endo-2-azabicicloalcano-3-carboxilico
UA50730C2 (uk) Спосіб одержання 1-(тіометил)циклопропаноцтової кислоти та проміжних сполук для її одержання
DK0701623T3 (da) Fremgangsmåde til fremstilling af N-acetyl-neuraminsyre
DK0778262T3 (da) Fremgangsmåde til oprensning af (RR,SS)-2-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexanol og dets salte
BR0315254A (pt) Processo para a fabricação de um composto, e, composto
ATE250430T1 (de) Verfahren zur entfernung von aromatischen verbindungen aus produkthaltigen lösungen
ES2132872T3 (es) Procedimiento de purificacion de diacetilreina.
ATE191450T1 (de) Verfahren zur nitrierung von diphenyl ether verbindungen
DE69430077D1 (de) Verfahren zur Herstellung von Zwischenprodukten, die für die Herstellung von Retroviral-Protease hemmenden Verbindungen verwendbar sind
ES2137999T3 (es) Procedimiento para sintetizar intermedios utiles de compuestos de imidazol sustituidos.
YU25196A (sh) SINTEZA INTERMEDIJARA ZA DOBIJANJE 5,6-DIHIDRO-(S)-4-(ETILAMINO)-(S)-6-METIL-4H-TIENO[2,3b]TIOPIRAN-2-SULFONAMID 7,7 DIOKSID INTERMEDIJERA SRODNIH JEDINJENJA
DE69617079D1 (de) Verfahren zur Spaltung von Nebenprodukten aus der Direktsynthese von Alkylchlorsilane
NO953976D0 (no) Deallyleringsreagens og fremgangsmåte for deallylering ved anvendelse av det nevnte reagens
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici
ATE165096T1 (de) Verfahren für die synthese von 9-(2- hydroxyethoxymethyl)guanin
ATE261931T1 (de) Verfahren zur synthese alpha-substituierter ringsysteme
ATE169908T1 (de) Verfahren zur herstellung von gegebenenfalls 2- substituierten 5-chlorimidazol-4-carbaldehyden
KR960037666A (ko) 1-(2-클로로페닐)-5(4h)-테트라졸리논의 제조방법
DE69726293D1 (de) Verfahren zur selektiven alkylierung von epoxyalkoholen
ATE204193T1 (de) Verfahren zur umkehrphasen-chromatographie

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 868423

Country of ref document: ES